From Financial Modeling Prep: 2024-12-02 12:17:00

Morgan Stanley upgraded Stryker (NYSE:SYK) from Equalweight to Overweight with a new price target of $445, citing positive survey data and strong orthopedic demand trends.

A hospital survey indicated growing momentum for Stryker, with its Mako robotic system leading the orthopedic robotics market and showing share growth to 37%.

Large-joint orthopedic volumes in the second half of 2024 exceeded expectations, with 24% of respondents reporting volumes above forecasts.

Survey respondents projected a stable 3.5% increase in capital expenditure for 2025, aligning with Stryker’s expected performance in the market.



Read more at Financial Modeling Prep:: Morgan Stanley Upgrades Stryker to Overweight Amid…